FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair

Anika Announces FDA 510(k) Clearance for Its Injectable HA-Based Bone Repair Treatment

December 27, 2017 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on…